Superworth

AtriCure price to book ratio ATRC

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
5.8×
10-year median
4.4×
Against its 10-year history
76th
percentile: 0 is its lowest day, 100 its highest
10-year range
2.2× to 10.0×
Peer median
4.2×

AtriCure's price to book ratio is 5.8× as of Oct 23, 2026.

That is above its ten-year median of 4.4×, higher than on 76% of days in the last ten years.

Over that time it ranged from 2.2× in Jun 2024 to 10.0× in Aug 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 4.2×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far5.8×2.7×5.8×
20254.2×3.2×4.4×
20243.2×2.2×3.9×
20233.7×3.4×5.9×
20224.6×3.4×6.5×
20216.5×6.1×10.0×
20206.0×3.7×8.9×
20194.9×3.9×7.8×
20187.0×3.3×7.9×
20174.0×2.9×5.2×
20163.8×2.5×5.0×
20155.8×3.6×6.2×
20143.9×3.0×12.8×
201311.0×4.6×14.5×
20128.2×7.0×12.1×
201111.2×8.6×11.8×

Against its peers

Companies in Medical - Instruments & Supplies nearest AtriCure's size, closest first, today.

CompanyPrice to book ratio
ATRCAtriCure5.8×
WRBYWarby Parker8.2×
NVSTEnvista1.2×
UFPTUFP Technologies5.0×
ICUIICU Medical1.9×
INSPInspire Medical Systems2.5×
BMIBadger Meter6.4×
VNTVontier3.9×
LMATLemaitre Vascular4.6×
HAEHaemonetics6.4×
MMSIMerit Medical Systems3.3×
Peer median4.2×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on AtriCure

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.